[Histonet] IHC Billing - 88342 vs. 88341

[Perl , Alison]

Hi Dr Cartun
That was our worst-case scenario, but our LIS was able to build logic so that it will convert 88342 to 88341 after the 1st, for each specimen (rather than case). It's been working well for the past 6 months or so...

Alison Perl, HTL(ASCP)CM
Anatomic Pathology Manager 
CareMount Medical
(914) 302-8424
aperl at cmmedical.com


-----Original Message-----
From: Cartun, Richard via Histonet [mailto:histonet at lists.utsouthwestern.edu] 
Sent: Monday, January 21, 2019 3:20 PM
To: histonet at lists.utsouthwestern.edu
Subject: [EXTERNAL] [Histonet] IHC Billing - 88342 vs. 88341

For those of you doing clinical IHC testing, have you been able to automate the billing of IHC (88342 vs. 88341) or do you still manual bill?  Our IT staff wants to build-in a "88342" and a ""88341" for every antibody that we run and then have the pathologist select the appropriate one for billing.

Richard

Richard W. Cartun, MS, PhD
Director, Histology & The Martin M. Berman, MD Immunopathology/Morphologic Proteomics Laboratory
Director, Biospecimen Collection Programs
Assistant Director, Anatomic Pathology
Hartford Hospital
80 Seymour Street
Hartford, CT  06102
(860) 972-1596 (Office)
(860) 545-2204 (Fax)
Richard.cartun at hhchealth.org<mailto:Richard.cartun at hhchealth.org>


This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message, including any attachments.
_______________________________________________
Histonet mailing list
Histonet at lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

This email and its attachments, if any, may contain confidential or proprietary information and are intended solely for authorized use by the intended recipient(s) only. Any other use of this email is prohibited. If you have received this email in error, you are hereby notified that any retention, disclosure, copying, forwarding, distribution (in whole or in part and whether electronically, written and/or orally) and/or taking of any action in reliance on this email, its contents and/or any attachments thereto is strictly prohibited. If you received this email in error, please notify the sender by replying to this message and permanently delete this email, and any attachments thereto, from your system immediately.